Karen D Tsuchiya
Overview
Explore the profile of Karen D Tsuchiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
705
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vanderscheldon R, Sukov W, Gardner J, Rehder C, Levy B, Velagaleti G, et al.
Genes (Basel)
. 2025 Jan;
15(12.
PMID: 39766879
The joint College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee works to ensure the competency and proficiency of clinical cytogenetic testing laboratories through proficiency testing (PT)...
2.
Boles B, Gardner J, Rehder C, Levy B, Velagaleti G, Toydemir R, et al.
Arch Pathol Lab Med
. 2024 Jun;
149(3):211-216.
PMID: 38838342
Context.—: The joint College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee works to ensure competency and proficiency of clinical cytogenetics testing laboratories through proficiency testing programs...
3.
Das M, Tsuchiya K, Bohling S, Davis B, Hwang S, Gardner R, et al.
Pediatr Dev Pathol
. 2023 Nov;
27(2):193-197.
PMID: 38032739
B-lymphoblastic leukemia/lymphoma (B-ALL/LBL) is a precursor B-cell neoplasm that often harbors specific cytogenetic/molecular abnormalities with distinctive clinical, phenotypic, and prognostic characteristics. Subcategorization of B-ALL/LBL therefore requires extensive cytogenetic and/or molecular...
4.
Tsuchiya K, Funke B, Hegde M, Santani A, Souers R, Szelinger S, et al.
Arch Pathol Lab Med
. 2023 Oct;
148(7):775-783.
PMID: 37852169
Context.—: Next-generation sequencing (NGS)-based assays are used for diagnosis of diverse inherited disorders. Limited data are available pertaining to interlaboratory analytical performance of these assays. Objective.—: To report on the...
5.
Koleilat A, Smadbeck J, Zepeda-Mendoza C, Williamson C, Pitel B, Golden C, et al.
Genes Chromosomes Cancer
. 2022 Jun;
61(12):710-719.
PMID: 35771717
Acute lymphoblastic leukemia (B-ALL) with intrachromosomal amplification of chromosome 21 (iAMP21-ALL) represents a recurrent high-risk cytogenetic abnormality and accurate identification is critical for appropriate clinical management. Identification of iAMP21-ALL has...
6.
Chisholm K, Bohling S, Tsuchiya K, Paulson V
Pediatr Dev Pathol
. 2022 May;
25(5):538-547.
PMID: 35583198
Background: Kikuchi-Fujimoto disease (KFD) is a rare, benign, and self-limited disease that presents with cervical lymphadenopathy and systemic symptoms. Histologic evaluation is often necessary to differentiate KFD from other entities....
7.
Nardi V, Tsuchiya K, Kim A, Bean L, Halley J, Long T, et al.
Arch Pathol Lab Med
. 2021 Aug;
146(4):451-461.
PMID: 34424952
Context.—: Next-generation sequencing-based assays are increasingly used in clinical molecular laboratories to detect somatic variants in solid tumors and hematologic malignancies and to detect constitutional variants. Proficiency testing data are...
8.
Mascarello J, Hirsch B, Kearney H, Ketterling R, Olson S, Quigley D, et al.
Genet Med
. 2019 Apr;
21(10):2405.
PMID: 31028353
No abstract available.
9.
Geiersbach K, Bridge J, Dolan M, Jennings L, Persons D, Souers R, et al.
Arch Pathol Lab Med
. 2018 May;
142(10):1254-1259.
PMID: 29733681
Context.—: Fluorescence in situ hybridization (FISH) and brightfield in situ hybridization (ISH) are 2 clinically approved laboratory methods for detecting ERBB2 (HER2) amplification in breast cancer. Objective.—: To compare the...
10.
Chisholm K, Xu M, Davis B, Ogi A, Pacheco M, Geddis A, et al.
Am J Clin Pathol
. 2018 Apr;
149(6):499-513.
PMID: 29659673
Objectives: To evaluate the utility of flow cytometry, karyotype, and a fluorescence in situ hybridization (FISH) panel in screening children for myelodysplastic syndrome (MDS). Methods: Bone marrow morphology, flow cytometry,...